Alumni - Current Positions

If you are an alumnus and your information is not up to date, please contact Aileen Rosales at  (212) 746-6250 to provide us with your current information.   

(updated 05/2023)

Name Year of Graduation Advisor's Name Thesis Project Current Position
Kyle Planck 2023 Kyu Rhee

Harnessing Chemical Biology and Metabolomics for Preclinical TB Drug Discovery

Technical Advisor - McDonnell Boehnen Hulbert & Berghoff LLP
Thomas Rossetti 2023 Jochen Buck and Lonny Levin

Optimizing Small Molecule Inhibitors of Soluble Adenylyl Cyclase (sAC) for Use as Male Contraceptives

Postdoctoral Associate - Buck & Levin Lab

Pedro Silberman 2023 David Scheinberg

Tumor Microenvironment Actuated T-Cells (MEAT-Cells) to Conditionally Express Chimeric Antigen Receptors and Mitigate Lethal Toxicity

Medical Student, The Ohio State University

Daniel Tylawsky 2023 Daniel Heller

Drug Delivery to Intracranial Tumors by Active Transport of Targeted Nanocarriers

Research Scholar at Memorial Sloan Kettering Cancer Center

Jiayi (Cassie) Yuan 2023 Lorenz Studer

Genome-Wide Loss-of-Function Screens in Human Microglia to Identify Novel HSV1 Susceptibility Factors

Clinical Scientist Intern at Genentech

Madeline Dorso 2022 Sarat Chandarlapaty

Characterization of FOXA1-Glucocorticoid Receptor as a Therapeutic Target in Non-Small Cell Lung Cancer

Senior Research Scientist - Arvinas, Inc.

Arijh Elzein 2022 David Solit

Predicting Oncogenic p110δ Mutants Using A Quantitative Paralogy Algorithm

Research Fellow - MSKCC

Heather Jones 2022 David Scheinberg

Modulating the Target Specificity of TCRs

Scientist at T Scan - Boston, MA

Joshua Korsen 2022 Jason Lewis

Molecular Imaging and Radioimmunotherapy Targeting Delta-like Ligand 3 in Neuroendocrine Prostate Cancer

Biotech Equity Research Associate at H.C. Wainwright & Co., LLC

Joanna Luo 2022 Yueming Li

Mechanism of Gamma-Secretase Modulators: From Tools to Therapeutics

Research Fellow at Albert Einstein College of Medicine

Joyce Pasion 2022 Hans Guido-Wendel

Loss of Bromodomain-Containing Protein 9 (BRD9)  Reprograms Tumor Response to Natural Killer (NK) Cell-Mediated Killing

N/A

Ramya Sridharan 2022 Daniel Heller

Caveolin-mediated Transport as a Driver of Drug Delivery in KRAS Mutant Cancers

Sr. Assoc. Consultant for Prescient Healthcare Consulting Group

Mitchell Wang 2022 Morgan Huse

Mechanoregulation of Cytotoxic T Lymphocyte Killing 

Scientist, Mnemo Therapeutics - NYC

Christina Bebernitz 2021 Renier Brentjens

IL-12 and IL-18 Combination Improves Activation of Adoptively Transferred T cells in Solid Tumors

Equity Research Associate at SVB Leerink

Karen Chu 2021 Kharas/Leslie

Identifying the MUSASHI-2 Network and its Functional Impact in Normal and Malignant Blood

TBA